vidarabine has been researched along with Leukemia, Prolymphocytic in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (55.56) | 18.2507 |
2000's | 5 (27.78) | 29.6817 |
2010's | 3 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergmann, L; Chow, KU; Cordes, HJ; Kim, SZ; Schlegelberger, B; Stilgenbauer, S; von Neuhoff, N; Wunderle, L | 1 |
Rossi, D | 1 |
Appelbaum, FR; Belch, A; Kolitz, JE; Larson, RA; Morrison, VA; Peterson, BL; Rai, KR; Solh, M; Tallman, MS | 1 |
Hirayama, Y; Kawano, Y; Kogawa, K; Kuribayashi, K; Matsunaga, T; Murase, K; Niitsu, Y; Okamoto, T; Sato, T; Takayama, T; Watanabe, H | 1 |
Bulanov, AIu; Chernova, NG; Gretsov, EM; Kalinin, NN; Kravchenko, SK; Kremenetskaia, AM; Mar'in, DS; Petrova, VI; Semenova, EA; Valiev, TT; Vinogradova, IuE; Volkova, IaK; Vorob'ev, AI | 1 |
Robak, P; Robak, T | 1 |
Lundberg, JH; Tefferi, A; Weitz, JJ; Witzig, TE | 1 |
Doorduijn, JK; Michiels, JJ | 1 |
Bendandi, M; Tabanelli, M; Tura, S; Zinzani, PL | 1 |
Cannon, LM; Garfinkel, H; Pezzimenti, J; Rhodes, R; Spilove, L | 1 |
Bowen, AL; Catovsky, D; Dyer, MJ; Emmett, E; Matutes, E; Zomas, A | 1 |
Crollo, R; D'Oronzio, L; Dambra, P; Dell'Osso, A; Grande, M; Lasaracina, E; Loria, MP; Lucivero, G | 1 |
Andrieu, V; Carbon, C; Couvelard, A; Encaoua, R; Grange, MJ | 1 |
Catovsky, D; Dearden, CE; Matutes, E | 1 |
Ayres, M; Du, M; Gandhi, V; Hodge, JP; Keating, MJ; O'Brien, S; Plunkett, W; Ramakrishna, P; Rodriguez, CO; Rosner, GL; Weller, S | 1 |
Marlton, P; McCarthy, C; Taylor, K | 1 |
Sporn, JR | 1 |
Beran, M; Childs, C; Huh, Y; Kantarjian, HM; Keating, MJ; Koller, C; O'Brien, S; Schachner, J | 1 |
1 review(s) available for vidarabine and Leukemia, Prolymphocytic
Article | Year |
---|---|
Current treatment options in prolymphocytic leukemia.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Cladribine; Drug Therapy; Humans; Leukemia, Prolymphocytic; Pentostatin; Purine Nucleosides; Rituximab; Splenectomy; Stem Cell Transplantation; Vidarabine | 2007 |
3 trial(s) available for vidarabine and Leukemia, Prolymphocytic
Article | Year |
---|---|
Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Epirubicin; Female; Humans; Immunotherapy; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Male; Middle Aged; Prospective Studies; Rituximab; Vidarabine | 2011 |
Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Arabinonucleotides; Biomarkers; Female; Guanosine Triphosphate; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Prolymphocytic; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Treatment Outcome; Vidarabine | 2001 |
Efficacy of fludarabine, a new adenine nucleoside analogue, in patients with prolymphocytic leukemia and the prolymphocytoid variant of chronic lymphocytic leukemia.
Topics: Aged; Aged, 80 and over; Agranulocytosis; Antineoplastic Agents; Chromosome Aberrations; Chromosome Disorders; Female; Humans; Immunoglobulin M; Karyotyping; Leukemia, Prolymphocytic; Male; Middle Aged; Prednisone; Remission Induction; Vidarabine | 1991 |
14 other study(ies) available for vidarabine and Leukemia, Prolymphocytic
Article | Year |
---|---|
Richter syndrome and fludarabine: a controversial relationship.
Topics: Antineoplastic Agents; Cell Transformation, Neoplastic; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Male; Vidarabine | 2013 |
The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011).
Topics: Adult; Aged; Antineoplastic Agents; Cell Transformation, Neoplastic; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Male; Middle Aged; Neoplasm Staging; Treatment Outcome; Vidarabine | 2013 |
Allogeneic bone marrow transplantation in a patient with T-prolymphocytic leukemia with small-intestinal involvement.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Drug Resistance, Neoplasm; Humans; Intestinal Polyposis; Leukemia, Prolymphocytic; Leukemia, T-Cell; Male; Prednisone; Transplantation, Homologous; Treatment Outcome; Vidarabine; Vincristine | 2003 |
[Remission in T-cell prolymphocytic leukemia during the FMC treatment course].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Leukemia, Prolymphocytic; Leukemia, T-Cell; Male; Middle Aged; Mitoxantrone; Remission Induction; Vidarabine | 2006 |
Treatment of refractory T-cell chronic lymphocytic leukemia with purine nucleoside analogues.
Topics: 2-Chloroadenosine; Anemia; Antineoplastic Combined Chemotherapy Protocols; CD3 Complex; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclophosphamide; Deoxyadenosines; Fatal Outcome; Female; Humans; Immunophenotyping; Leukemia, Prolymphocytic; Leukemia, Prolymphocytic, T-Cell; Male; Methotrexate; Middle Aged; Neoplastic Stem Cells; Prednisone; Salvage Therapy; Vidarabine; Vincristine; Zidovudine | 1994 |
Effectiveness of fludarabine in end-stage prolymphocytic leukemia.
Topics: Aged; Anemia; Antigens, CD; Antineoplastic Agents; Blood Transfusion; Chlorambucil; Female; Humans; Immunophenotyping; Leukemia, Prolymphocytic; Neoplasm Staging; Splenectomy; Thrombocytopenia; Vidarabine | 1994 |
Prolonged bone marrow aplasia of refractory prolymphocytoid variant of B-cell chronic lymphocytic leukemia related to fludarabine treatment.
Topics: Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Leukopenia; Male; Middle Aged; Neutropenia; Vidarabine | 1994 |
Acute tumor lysis syndrome complicating fludarabine treatment of prolymphocytic leukemia.
Topics: Acute Disease; Aged; Antineoplastic Agents; Fatal Outcome; Female; Humans; Leukemia, Prolymphocytic; Tumor Lysis Syndrome; Vidarabine | 1993 |
Subcutaneous CAMPATH-1H in fludarabine-resistant/relapsed chronic lymphocytic and B-prolymphocytic leukaemia.
Topics: Administration, Cutaneous; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Drug Resistance, Neoplasm; Female; Humans; Leukemia, B-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Male; Recurrence; Vidarabine | 1997 |
Phenotypic changes of leukemic cells in a patient with prolympho-plasmacytic leukaemia after treatment with fludarabine.
Topics: Aged; Antigens, CD; Antineoplastic Agents; Humans; Immunophenotyping; Immunosuppressive Agents; Leukemia, Plasma Cell; Leukemia, Prolymphocytic; Lymphocytes; Male; Phenotype; Vidarabine | 1997 |
Leukemic pleural effusion in B-cell prolymphocytic leukemia.
Topics: Aged; Antibodies; Antigens, CD20; Antineoplastic Agents; Humans; Immunohistochemistry; Leukemia, B-Cell; Leukemia, Prolymphocytic; Male; Pleural Effusion, Malignant; Remission Induction; Tomography Scanners, X-Ray Computed; Vidarabine | 1998 |
Clinical overview of pentostatin (Nipent) use in lymphoid malignancies.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Drug Resistance, Neoplasm; Follow-Up Studies; Humans; Immunosuppressive Agents; Leukemia; Leukemia, B-Cell; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Leukemia, T-Cell; Lymphoma; Lymphoma, B-Cell; Lymphoma, T-Cell; Pentostatin; Sezary Syndrome; Survival Rate; Vidarabine | 2000 |
Fludarabine-induced cytogenetic remission in prolymphocytic leukemia.
Topics: Aged; Chromosome Aberrations; Chromosome Disorders; Humans; Karyotyping; Leukemia, Prolymphocytic; Male; Vidarabine | 1992 |
Sustained response of refractory prolymphocytic leukemia to fludarabine.
Topics: Aged; Antimetabolites, Antineoplastic; Humans; Leukemia, Prolymphocytic; Leukocyte Count; Male; Remission Induction; Spleen; Vidarabine | 1991 |